Back
Allogene Therapeutics Quote, Financials, Valuation and Earnings
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
26
ALLO
Allogene Therapeutics
Last Price:
3.07
Seasonality Move:
10.59%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surgeAllogene Therapeutics Price Quote
$3.07
+0.10 (+3.37%)
(Updated: May 3, 2024 at 6:40 PM ET)
Allogene Therapeutics Key Stats
Sell
26
Allogene Therapeutics (ALLO)
is a Sell
Day range:
$2.92 - $3.09
52-week range:
$2.23 - $6.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4,904.20
P/B ratio:
0.98%
Volume:
1.4M
Avg. volume:
1.8M
1-year change:
-44.49%
Market cap:
$502.2M
Revenue:
$95K
EPS:
$-2.12
How Much Does Allogene Therapeutics Make?
-
How Much Are Allogene Therapeutics's Sales Annually?
ALLO Revenues are $95K -
How Much Profit Does Allogene Therapeutics's Make A Year?
ALLO net income is -$327.3M
Is Allogene Therapeutics Growing As A Company?
Data Unavailable
Allogene Therapeutics Stock Price Performance
-
Did Allogene Therapeutics Stock Go Up Last Month?
Allogene Therapeutics share price went down by -27.03% last month -
Did ALLO's Share Price Rise Over The Last Year?
ALLO share price fell by -44.49% over the past 1 year
What Is Allogene Therapeutics 52-Week High & Low?
-
What Is Allogene Therapeutics’s 52-Week High Share Price?
Allogene Therapeutics has traded as high as $6.89 over the past 52 weeks -
What Is Allogene Therapeutics’s 52-Week Low Share Price?
Allogene Therapeutics has traded as low as $2.23 over the past 52 weeks
Allogene Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Allogene Therapeutics?
-
How Much Debt Does Allogene Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Allogene Therapeutics Have?
Cash and short term investments quarterly total is $448.7M -
What Is Allogene Therapeutics’s Book Value Per Share?
Book value per share is 3.04
Is Allogene Therapeutics Cash Flow Positive?
-
What Is ALLO Cash Flow From Operations?
Cash flow from operations (TTM) is -$237.7M -
What Is Allogene Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $95.7M -
What Is Allogene Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $163.3M
Allogene Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ALLO return on invested capital is -54.96% -
What Is Allogene Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -44.29% -
What Is ALLO Return On Equity?
ROE is a measure of profitability and is -54.96%
Allogene Therapeutics Earnings Date & Stock Price
-
What Is Allogene Therapeutics's Stock Price Today?
A single share of ALLO can be purchased today for 2.97 -
What Is Allogene Therapeutics’s Stock Symbol?
Allogene Therapeutics trades on the nasdaq under the ticker symbol: ALLO -
When Is Allogene Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Allogene Therapeutics is scheduled on May 3, 2024 -
When Is ALLO's next ex-dividend date?
Allogene Therapeutics's next ex-dividend date is May 3, 2024 -
How To Buy Allogene Therapeutics Stock?
You can buy Allogene Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Allogene Therapeutics Competitors
-
Who Are Allogene Therapeutics's Competitors?
Below is a list of companies who compete with Allogene Therapeutics or are related in some way:
Allogene Therapeutics Dividend Yield
Data Unavailable
Allogene Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -16.72% |
| Revenue: | 0% | -6.25% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 11.66 |
| Upside from Last Price: | 292.54% |